Nektar Therapeutics Tumbles Despite Long-Term Benefit From Alopecia Drug

Nektar Therapeutics stock took a hit Thursday despite test results that suggested its drug has long-term benefits for alopecia patients. The post Nektar Therapeutics Tumbles Despite Long-Term Benefit From Alopecia Drug appeared first on Investor's Business Daily.